The Europe Vaccines Market is expected to reach US$ 16,291.0 Mn in 2027 from US$ 9,576.2 Mn in 2018. The market is estimated to grow with a CAGR of 5.5% from 2019-2027.
The growth of the market is driven by the factors such as increasing awareness programs for vaccination in Europe and increasing vaccines research, and development activities in Europe are likely to grow the vaccines market in the forecast period. Whereas, the vaccines hesitancy in the European region is likely to impact the growth of the vaccines market during the forecast period.
Vaccination saves lives and improves quality of life. For instance, Polio is an infectious disease caused by poliovirus and causes muscle weakness that results in an inability to move, which further hampers the quality of life. Polio vaccine protects an individual against polio. The vaccine produces antibodies in the bloodstream against the poliovirus. Due to the strong promotion of Polio vaccine in Europe, the World Health Organization in 2002, declared the European Region polio-free.
The countries in the European region are joining forces to eradicate infectious diseases like measles, diphtheria, rubella, pertussis, and others through vaccinations. There are several vaccination programs, campaigns, conferences, being held in the European region in order to raise awareness among the population. For instance, European Immunization Week (EIW) is renowned across the European Region and is celebrated every April to raise awareness of the importance of vaccination for people’s health and well-being. European Centre for Disease Prevention and Control (ECDC) supports the European Immunization Week campaign undertook by WHO/Europe and provides scientific evidence on vaccination.
Furthermore, 38th Euro Global Summit and Expo on Vaccines & Vaccination will be held in June 2020 Frankfurt, Germany. The conference focuses on discussing novel strategies in vaccines and immunology research. The aim of the conference is to encourage quality research and to bring together world-class researchers, international communities, and industrial heads to discuss the new developments and innovations in the fields of vaccines and immunology.
The Germany vaccines market is expected to grow at the highest rate during the forecast period due to the driving factors such as growing awareness programs and large funding for development of vaccines. The robust R&D activities in the country are likely to drive the market for vaccination in the country. The growth rate of the market in the region is estimated to be 6.4% during the forecast period. Therefore, considering the above mentioned factors, the growth of the market in the country is likely to contribute the largest share in the Europe region during the forecast period.
Rest of Europe Vaccines Market Revenue and Forecasts to 2027 ( US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
EUROPE VACCINES– MARKET SEGMENTATION
By Technology
- Recombinant vaccines
- Conjugate Vaccines
- Live Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
EUROPE VACCINES – MARKET SEGMENTATION
By Disease Indication
- DTP (diphtheria, tetanus, and pertussis)
- Influenza
- Hepatitis
- Other Diseases
EUROPE VACCINES – MARKET SEGMENTATION
By Rout of Administration
- Oral
- Injectable
- Other
EUROPE VACCINES – MARKET SEGMENTATION
By Patient Type
- Adults
- Pediatric
By Country
- Germany
- France
- UK
- Italy
- Spain
Companies Mentioned
- PFIZER INC
- GlaxoSmithKline plc.
- Merck & Co., Inc.
- Sanofi
- Johnson & Johnson Services, Inc
- Panacea Biotec Limited
- Astellas Pharma Inc.
- NOVAVAX, INC.
- VBI Vaccines Inc
- Bavarian Nordic
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
2. Europe Vaccines Market – Key Takeaways
3. Europe Vaccines Market – Market Landscape
3.1 overview
3.2 Market Segmentation
3.2.1 Europe Vaccines Market – By Technology
3.2.2 Europe Market – By Disease Indication
3.2.3 Europe Vaccines Market – By Route of Administration
3.2.4 Europe Vaccines Market – By Patient Type
3.2.5 Europe Vaccines Market – By Country
3.3 PEST Analysis
4. Europe Vaccines Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Growing Awareness Programs for Vaccination in Europe
4.1.2 Increasing Vaccines Research and Development Activities in Europe.
4.2 Key Market Restraints
4.2.1 Vaccines Hesitancy in the European region.
4.3 Key Market Opportunities
4.3.1 Growing Prevalence of Infectious Diseases
4.4 Future Trends
4.4.1 New Vaccines In Development
4.5 Impact Analysis
5. Vaccines Market – Europe Analysis
5.1 Europe Vaccines Market Revenue Forecasts and Analysis
5.2 Market Positioning
5.3 Performance of Key Players
5.3.1 Sanofi
6. Europe Vaccines Market Analysis – By Technology
6.1 Overview
6.2 Europe Vaccines Market, By Type, 2018 & 2027 (%)
6.3 Europe Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
6.4 Europe Recombinant Vaccines Market
6.4.1 Overview
6.4.2 Europe Recombinant Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Europe Conjugate Vaccines Market
6.5.1 Overview
6.5.2 Europe Conjugate Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
6.6 Europe Live Attenuated Vaccines Market
6.6.1 Overview
6.6.2 Europe Live Attenuated Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
6.7 Europe Inactivated Vaccines Market
6.7.1 Overview
6.7.2 Europe Inactivated Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
6.8 Europe Toxoid Vaccines Market
6.8.1 Overview
6.8.2 Europe Toxoid Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
7. Europe Vaccines Market Analysis – By Disease Indication
7.1 Overview
7.2 Europe Vaccines Market, By Disease Indication, 2018 & 2027 (%)
7.3 Europe Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
7.4 Europe DTP (Diphtheria, Tetanus, And Pertussis) Market
7.4.1 Overview
7.4.2 Europe DTP (Diphtheria, Tetanus, And Pertussis) Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Europe Influenza Market
7.5.1 Overview
7.5.2 Europe Influenza Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Europe Hepatitis Market
7.6.1 Overview
7.6.2 Europe Hepatitis Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Europe Other Diseases Market
7.7.1 Overview
7.7.2 Europe Other Diseases Market Revenue and Forecast to 2027 (US$ Mn)
8. Europe Vaccines Market Analysis – By Route of Administration
8.1 Overview
8.2 Europe Vaccines Market, By Route of Administration, 2018 & 2027 (%)
8.3 Europe Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
8.4 Europe Oral Market
8.4.1 Overview
8.4.2 Europe Oral Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Europe Injectable Market
8.5.1 Overview
8.5.2 Europe Injectable Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Europe Other Routes of Administration Market
8.6.1 Overview
8.6.2 Europe Other Routes of Administration Market Revenue and Forecast to 2027 (US$ Mn)
9. Europe Vaccines Market Analysis – By Patient Type
9.1 Overview
9.2 Europe Vaccines Market, By Patient Type, 2018 & 2027 (%)
9.3 Europe Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
9.4 Europe Pediatric Market
9.4.1 Overview
9.4.2 Europe Pediatric Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Europe Adults Market
9.5.1 Overview
9.5.2 Europe Adults Market Revenue and Forecast to 2027 (US$ Mn)
10. Europe Vaccines Market Revenue And Forecasts To 2027
10.1.1 Europe Vaccines Market Revenue Overview, by Country (2017) (US$ Mn)
10.1.2 Europe Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.3 Europe Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.4 Europe Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.5 Europe Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.6 Europe Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
10.1.7 Europe Vaccines Market Revenue and Forecasts to 2027, By Country (%)
10.1.8 Germany Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9 Germany Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9.1 Germany Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.9.2 Germany Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.9.3 Germany Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.9.4 Germany Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
10.1.10 UK Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.11 UK Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.11.1 UK Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.11.2 UK Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.11.3 UK Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.11.4 UK Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
10.1.12 France Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.13 France Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.13.1 France Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.13.2 France Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.13.3 France Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.13.4 France Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
10.1.14 Italy Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.15 Italy Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.15.1 Italy Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.15.2 Italy Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.15.3 Italy Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.15.4 Italy Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
10.1.16 Spain Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.17 Spain Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.17.1 Spain Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.17.2 Spain Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.17.3 Spain Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.17.4 Spain Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
11. Vaccines Market –Industry Landscape
11.1 Overview
11.2 Comparative Company Analysis
11.3 Growth Strategies Done by the Companies in the Market, (%)
11.4 Organic Developments
11.4.1 Overview
11.5 Inorganic Developments
11.5.1 Overview
12. Vaccines Market–Key Company Profiles
12.1 Pfizer Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 GlaxoSmithKline plc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Merck & Co., Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sanofi
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Information
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Johnson & Johnson Services, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Panacea Biotec Limited
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Information
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Astellas Pharma Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 Swot Analysis
12.7.6 Key Developments
12.8 NOVAVAX, INC.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Information
12.8.4 Product Pipeline
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 VBI Vaccines Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Information
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 BAVARIAN NORDIC
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Information
12.10.4 Product Pipeline
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
13.3 Methodology
13.3.1 Coverage
13.3.2 Secondary Research
13.3.3 Primary Research
LIST OF TABLES
Table 1. Europe Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 2. Europe Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 3. Europe Vaccines Market Revenue And Forecasts to 2027, By route of administration (US$ Mn)
Table 4. Europe Vaccines Market Revenue And Forecasts to 2027, By patient type (US$ Mn)
Table 5. Europe Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 6. Europe Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 7. Europe Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
Table 8. Europe Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
Table 9. Germany Vaccines Market Revenue And Forecasts To 2027, By Technology (US$ Mn)
Table 10. Germany Vaccines Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 11. Germany Vaccines Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
Table 12. Germany Vaccines Market Revenue And Forecasts To 2027, By Patient Type (US$ Mn)
Table 13. UK Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 14. UK Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 15. UK Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
Table 16. UK Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
Table 17. France Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 18. France Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 19. France Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
Table 20. France Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
Table 21. Italy Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 22. Italy Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 23. Italy Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
Table 24. Italy Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
Table 25. Spain Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 26. Spain Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 27. Spain Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
Table 28. Spain Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
Table 29. Organic Developments Done By Companies
Table 30. Inorganic Developments Done by Companies
Table 31. Glossary of Terms, Vaccines market
The List of Companies - Europe Vaccines Market
- PFIZER INC
- GlaxoSmithKline plc.
- Merck & Co., Inc.
- Sanofi
- Johnson & Johnson Services, Inc
- Panacea Biotec Limited
- Astellas Pharma Inc.
- NOVAVAX, INC.
- VBI Vaccines Inc
- Bavarian Nordic
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Europe Vaccines Market
Jun 2019
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2019
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2019
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2019
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2019
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2019
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jun 2019
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jun 2019
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)